UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000013842 |
|---|---|
| Receipt number | R000016042 |
| Scientific Title | A study of the effect and safety of transcutaneous application of carbon dioxide on post-polio syndrome. |
| Date of disclosure of the study information | 2014/06/01 |
| Last modified on | 2016/11/10 15:02:10 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study of the effect and safety of transcutaneous application of carbon dioxide on post-polio syndrome.
Acronym
The effect of transcutaneous application of CO2 on post-plio syndrome.
Scientific Title
A study of the effect and safety of transcutaneous application of carbon dioxide on post-polio syndrome.
Scientific Title:Acronym
The effect of transcutaneous application of CO2 on post-plio syndrome.
Region
| Japan |
Condition
Condition
Post-Polio Syndrome
Classification by specialty
| Neurology | Rehabilitation medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluation of efficiacy and safety of novel transcutaneous application of carbon dioxide in the patients with post-polio syndrome.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Electromyogram
Visual analog scales for coldness, pain, fatigue and general conditions.
Muscle power
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Device,equipment |
Interventions/Control_1
Transcutaneous application of CO2
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. patients with muscle weakness in post polio syndrome
2. patients who are 20 years old or older
3. patients who can obtain informed consent with written by themselves or regal representive.
Key exclusion criteria
1.Patients with arteriosclerosis obliterans (Fontaine III-IV)
2.Patients with chronic heart failure (NYHA IV)
3.Possibility of pregnancy
4.Respiratory failure (%VC60% or less)
5. Severe anemia (Hb 7.0 g/dl or less
6.Large skin ulcer or severe skin disorder
7.Researcher's decision of unsuitable
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yoshitada Sakai |
Organization
Kobe University Graduate School of Medicine
Division name
Division of Rehabilitation Medicine
Zip code
Address
7-5-1 Kusunoki-cho, Chuo-ku , Kobe, Japan
TEL
078-382-6826
yossie@med.kobe-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yoshitada Sakai |
Organization
Kobe University Graduate School of Medicine
Division name
Division of Rehabilitation Medicine
Zip code
Address
7-5-1 Kusunoki-cho, Chuo-ku , Kobe, Japan
TEL
078-382-6826
Homepage URL
yossie@med.kobe-u.ac.jp
Sponsor or person
Institute
Kobe University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Kobe University Graduate School of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 06 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2014 | Year | 06 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 06 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2014 | Year | 04 | Month | 30 | Day |
Last modified on
| 2016 | Year | 11 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016042
